Dr. Kerrie P. Nelson's lab focuses on developing better tools for predicting the risk of colorectal cancer specifically in Black Americans, who face higher rates of the disease. The lab uses large data sets from studies of Black communities to create personalized risk assessments that take into account various lifestyle and demographic factors. By improving these prediction models, the lab aims to enhance early detection and prevention strategies, ultimately lowering colorectal cancer mortality rates.

Dr. Chunyu Liu's lab at Boston University Medical Campus focuses on understanding how alcohol consumption affects cardiovascular disease through a multi-omic approach. They utilize advanced techniques to analyze DNA, RNA, proteins, and metabolites in relation to alcohol use and its health impacts. By identifying molecular markers associated with alcohol intake, the lab aims to uncover pathways that could lead to better prevention and treatment strategies for cardiovascular disease.

Dr. Helen E. Jenkins' lab focuses on understanding how geographic barriers impact access to tuberculosis (TB) services in urban areas of middle-income countries. The research aims to improve TB diagnosis and treatment by identifying specific access challenges faced by disadvantaged populations. By applying advanced statistical methods and community survey data, the lab seeks to develop targeted interventions to help communities overcome barriers to effective healthcare.